RoboCT Secures ￥10 Million in Series A Funding

(VCBeat) Mar. 30, 2021 -- Hangzhou RoboCT Technology Development Co., Ltd. ("RoboCT") recently announced the completion of a Series A funding round of tens of millions from BlueRun Ventures.  The funding will be used for the exploration, market promotion, team expansion and mass production preparation of the new model of "Rehabilitation as a Service" for the elderly. This follows a Series Pre-A round led by Naton Medical, a healthcare group.

Founded in 2017, RoboCT is a high-tech company focusing on exoskeletons and rehabilitation robotics. Its founding team consists of experts in the fields of machinery, automation, communications, and computers, bringing together a number of academicians, medical association chairmen, brain and neurological experts, experts of bionics and more than 20 rehabilitation experts to build competitive expert networks.

At present, RoboCT focuses on the field of elderly care and rehabilitation, providing smart rehabilitation equipment, accessories and intelligent rehabilitation solutions for patients with mobility disability and the elderly.

As a technology-based enterprise, RoboCT has mastered the core technologies of the whole chain of exoskeleton robots, such as motors, reducers, joint modules, sensors, etc. The company has applied for more than 150 independent intellectual property rights. In addition, as an innovative medical device, the exoskeleton robot developed by RoboCT has obtained the first registration certificate of the exoskeleton robot for central neuropathy in China.

Up to now, the new "Rehabilitation as a Service" mode of RoboCT has covered more than 30 hospitals in many cities through the three-level rehabilitation system (the acute period in the rehabilitation department of the third-grade hospitals, the convalescence period is in the second-grade rehabilitation hospitals and the maintenance period in communities or at home), and more than 20,000 new users have tried out the rehabilitation training of its exoskeleton robot.

BlueRun Ventures is an early-stage venture capital firm with offices in the United States, Shanghai, Beijing, and Korea. BlueRun Ventures invests in information technology, mobile, and consumer technologies, with an emphasis on early-stage mobile opportunities.

BlueRun Ventures has invested in over 160 companies, with select exits from PayPal (acquired by eBay), Waze (acquired by Google), Topsy (acquired by Apple), Coupa (NASDAQ: COUP), and more.